• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Computer simulation of the binding of amonafide and azonafide to DNA.

作者信息

Bear S, Remers W A

机构信息

Department of Pharmacology and Toxicology, College of Pharmacy, University of Arizona, Tucson 85721, USA.

出版信息

J Comput Aided Mol Des. 1996 Apr;10(2):165-75. doi: 10.1007/BF00402824.

DOI:10.1007/BF00402824
PMID:8741020
Abstract

Intercalative binding of the antitumor drugs amonafide and azonafide to the oligonucleotide duplex d(GGCCGGCCGG).d(CCGGCCGGCC) was compared using molecular dynamics in vacuum with the AMBER force field. A number of reasonable possible binding conformations were obtained, with the azonafide complexes favored over the amonafide complexes in net binding enthalpy. In comparison with amonafide, the larger chromophore of azonafide permits greater DNA distortion and wider side-chain swings, without falling out of the intercalation site. The best model obtained was used for further dynamics on amonafide and azonafide with solvent and counterions present, and again the azonafide complex had a more favorable enthalpy. Furthermore, the enthalpy change on going from solvent into the intercalation site was less unfavorable for azonafide. These results are consistent with the stronger DNA binding of azonafide compared to amonafide, as observed in relative melting transition temperature increases and tumor inhibition in cell cultures.

摘要

相似文献

1
Computer simulation of the binding of amonafide and azonafide to DNA.
J Comput Aided Mol Des. 1996 Apr;10(2):165-75. doi: 10.1007/BF00402824.
2
Analogues of amonafide and azonafide with novel ring systems.
J Med Chem. 2000 Aug 10;43(16):3067-73. doi: 10.1021/jm9905817.
3
Base sequence determinants of amonafide stimulation of topoisomerase II DNA cleavage.
Nucleic Acids Res. 1995 Jan 25;23(2):223-9. doi: 10.1093/nar/23.2.223.
4
Topoisomerase II-mediated DNA cleavage by amonafide and its structural analogs.氨萘非特及其结构类似物介导的拓扑异构酶II依赖性DNA切割
Mol Pharmacol. 1989 Sep;36(3):371-6.
5
Conformation and dynamics of drug-DNA intercalation.药物 - DNA 嵌入的构象与动力学
J Biomol Struct Dyn. 1992 Aug;10(1):97-139. doi: 10.1080/07391102.1992.10508633.
6
Identification and characterization of in vitro metabolites of 2-[2'-(dimethylamino)ethyl]-1,2-dihydro-3H-dibenz [de,h]isoquinoline-1,3-dione (Azonafide).2-[2'-(二甲氨基)乙基]-1,2-二氢-3H-二苯并[de,h]异喹啉-1,3-二酮(阿扎那非)的体外代谢产物的鉴定与表征
Drug Metab Dispos. 1998 Feb;26(2):105-9.
7
Theoretical studies of the intercalation of 9-hydroxyellipticine in DNA.9-羟基玫瑰树碱嵌入DNA的理论研究。
Biopolymers. 1996 Sep;39(3):309-26. doi: 10.1002/(SICI)1097-0282(199609)39:3%3C309::AID-BIP4%3E3.0.CO;2-S.
8
The geometry of intercalation complex of antitumor mitoxantrone and ametantrone with DNA: molecular dynamics simulations.抗肿瘤药米托蒽醌和氨甲蒽醌与DNA嵌入复合物的几何结构:分子动力学模拟
Acta Biochim Pol. 1998;45(1):1-11.
9
New analogues of amonafide and elinafide, containing aromatic heterocycles: synthesis, antitumor activity, molecular modeling, and DNA binding properties.含有芳香杂环的氨萘非特和依利萘非特新类似物:合成、抗肿瘤活性、分子模拟及DNA结合特性
J Med Chem. 2004 Mar 11;47(6):1391-9. doi: 10.1021/jm0308850.
10
Solution structure of the esperamicin A1-DNA complex.埃斯帕霉素A1-DNA复合物的溶液结构
J Mol Biol. 1997 Jan 17;265(2):173-86. doi: 10.1006/jmbi.1996.0719.

本文引用的文献

1
2-substituted 1,2-dihydro-3H-dibenz[de,h]isoquinoline-1,3-diones. A new class of antitumor agent.2-取代的1,2-二氢-3H-二苯并[de,h]异喹啉-1,3-二酮。一类新型抗肿瘤剂。
J Med Chem. 1993 Mar 19;36(6):765-70. doi: 10.1021/jm00058a014.
2
New anticancer agents.新型抗癌药物。
Cancer Chemother Biol Response Modif. 1994;15:130-51.
3
Amino-substituted 2-[2'-(dimethylamino)ethyl]-1,2-dihydro-3H- dibenz[de,h]isoquinoline-1,3-diones. Synthesis, antitumor activity, and quantitative structure--activity relationship.氨基取代的2-[2'-(二甲氨基)乙基]-1,2-二氢-3H-二苯并[de,h]异喹啉-1,3-二酮。合成、抗肿瘤活性及定量构效关系
J Med Chem. 1995 Mar 17;38(6):983-93. doi: 10.1021/jm00006a018.
4
Interactions of antitumor drugs with natural DNA: 1H NMR study of binding mode and kinetics.抗肿瘤药物与天然DNA的相互作用:结合模式和动力学的1H NMR研究
J Med Chem. 1984 Apr;27(4):450-65. doi: 10.1021/jm00370a007.
5
Theoretical studies of nucleic acid interactions. I. Estimates of conformational mobility in intercalated chains.
Biopolymers. 1983 Dec;22(12):2667-702. doi: 10.1002/bip.360221213.
6
Synthesis and mode(s) of action of a new series of imide derivatives of 3-nitro-1,8 naphthalic acid.一系列新型3-硝基-1,8-萘二甲酸酰亚胺衍生物的合成及其作用方式
Cancer Chemother Pharmacol. 1980;4(1):61-6. doi: 10.1007/BF00255461.
7
Structural aspects of drug-DNA complexes: molecular modelling of intercalative interactions.药物 - DNA 复合物的结构方面:嵌入相互作用的分子建模
Drugs Exp Clin Res. 1986;12(6-7):455-62.
8
In vitro toxicity and DNA cleaving capacity of benzisoquinolinedione (nafidimide; NSC 308847) in human leukemia.
Cancer Res. 1987 Feb 15;47(4):1040-4.
9
Prediction of DNA structure from sequence: a build-up technique.
Biopolymers. 1989 Jul;28(7):1195-222. doi: 10.1002/bip.360280703.
10
Steady-state fluorescence and molecular-modeling studies of tomaymycin-DNA adducts.托马霉素-DNA加合物的稳态荧光和分子模拟研究。
Biochemistry. 1991 May 7;30(18):4421-31. doi: 10.1021/bi00232a008.